Zhan Xianquan, Desiderio Dominic M
Charles B. Stout Neuroscience Mass Spectrometry Laboratory, University of Tennessee Health Science Center, Memphis, Tennessee 38163, USA.
Mass Spectrom Rev. 2005 Nov-Dec;24(6):783-813. doi: 10.1002/mas.20039.
This article will review the published research on the elucidation of the mechanisms of pituitary adenoma formation. Mass spectrometry (MS) plays a key role in those studies. Comparative proteomics has been used with the long-term goal to locate, detect, and characterize the differentially expressed proteins (DEPs) in human pituitary adenomas; to identify tumor-related and -specific biomarkers; and to clarify the basic molecular mechanisms of pituitary adenoma formation. The methodology used for comparative proteomics, the current status of human pituitary proteomics studies, and future perspectives are reviewed. The methodologies that are used in comparative proteomics studies of human pituitary adenomas are readily exportable to other different areas of cancer research.
本文将综述已发表的关于阐明垂体腺瘤形成机制的研究。质谱(MS)在这些研究中发挥着关键作用。比较蛋白质组学已被用于长期目标,即定位、检测和表征人类垂体腺瘤中差异表达的蛋白质(DEP);识别肿瘤相关和特异性生物标志物;并阐明垂体腺瘤形成的基本分子机制。本文综述了比较蛋白质组学所使用的方法、人类垂体蛋白质组学研究的现状以及未来展望。人类垂体腺瘤比较蛋白质组学研究中使用的方法很容易应用于癌症研究的其他不同领域。